InsiderTrades.com logo
Nvidia’s world of pain awaits
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Click play to stream The Final Frontier at no cost

ELVN Insider Trading

Insider Ownership Percentage: 29.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $44,638,962.37

Enliven Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Enliven Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enliven Therapeutics Share Price & Price History

Current Price: $24.92
Price Change: ▼ Price Decrease of -0.88 (-3.41%)
As of 11/14/2024 05:32 PM ET

This chart shows the closing price history over time for ELVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Watch this before it gets removed
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

Enliven Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/28/2024Benjamin HohlCFOSell6,250$28.56$178,500.00View SEC Filing Icon  
10/18/2024Anish PatelCOOSell716$30.00$21,480.00343,311View SEC Filing Icon  
10/18/2024Benjamin HohlCFOSell814$30.00$24,420.00View SEC Filing Icon  
10/18/2024Joseph P LyssikatosInsiderSell847$30.00$25,410.001,015,188View SEC Filing Icon  
10/18/2024Richard A HeymanDirectorSell817$30.00$24,510.00123,673View SEC Filing Icon  
10/18/2024Samuel KintzCEOSell924$30.00$27,720.001,002,892View SEC Filing Icon  
10/15/2024Richard A HeymanDirectorSell1,270$27.67$35,140.90124,490View SEC Filing Icon  
10/9/2024Joseph P LyssikatosInsiderSell37,878$28.16$1,066,644.481,016,035View SEC Filing Icon  
10/9/2024Samuel KintzCEOSell16,710$28.15$470,386.501,003,816View SEC Filing Icon  
10/8/2024Rahul D BallalDirectorSell10,420$28.17$293,531.4022,341View SEC Filing Icon  
10/7/2024Benjamin HohlCFOSell1,270$27.51$34,937.70View SEC Filing Icon  
10/7/2024Joseph P LyssikatosInsiderSell2,707$27.61$74,740.271,067,180View SEC Filing Icon  
10/7/2024Samuel KintzCEOSell2,730$27.50$75,075.001,033,793View SEC Filing Icon  
10/4/2024Benjamin HohlCFOSell10,218$27.51$281,097.18View SEC Filing Icon  
10/4/2024Joseph P LyssikatosInsiderSell7,522$27.51$206,930.221,069,887View SEC Filing Icon  
10/4/2024Richard A HeymanDirectorSell2,825$27.51$77,715.75125,760View SEC Filing Icon  
10/4/2024Samuel KintzCEOSell12,206$27.51$335,787.061,036,523View SEC Filing Icon  
10/1/2024Joseph P LyssikatosInsiderSell527$27.54$14,513.581,077,409View SEC Filing Icon  
10/1/2024Richard A HeymanDirectorSell518$27.54$14,265.72128,585View SEC Filing Icon  
10/1/2024Samuel KintzCEOSell526$27.54$14,486.041,048,729View SEC Filing Icon  
9/30/2024Benjamin HohlCFOSell2,000$25.33$50,660.00View SEC Filing Icon  
9/27/2024Benjamin HohlCFOSell4,250$24.27$103,147.50View SEC Filing Icon  
8/29/2024Joseph P LyssikatosInsiderSell12,000$22.49$269,880.001,077,936View SEC Filing Icon  
8/27/2024Benjamin HohlCFOSell4,250$22.54$95,795.00View SEC Filing Icon  
8/26/2024Samuel KintzCEOSell12,000$22.89$274,680.001,049,255View SEC Filing Icon  
8/15/2024Richard A HeymanDirectorSell1,270$23.25$29,527.50130,373View SEC Filing Icon  
7/31/2024Benjamin HohlCFOSell991$27.53$27,282.23View SEC Filing Icon  
7/31/2024Joseph P LyssikatosInsiderSell3,099$27.56$85,408.441,089,936View SEC Filing Icon  
7/31/2024Richard A HeymanDirectorSell1,702$27.51$46,822.02131,643View SEC Filing Icon  
7/31/2024Samuel KintzCEOSell2,270$27.56$62,561.201,061,255View SEC Filing Icon  
7/29/2024Benjamin HohlCFOSell5,250$26.68$140,070.00View SEC Filing Icon  
7/29/2024Joseph P LyssikatosInsiderSell12,000$26.70$320,400.001,093,035View SEC Filing Icon  
7/25/2024Samuel KintzCEOSell12,000$24.92$299,040.001,063,525View SEC Filing Icon  
7/15/2024Anish PatelCOOSell30,978$25.05$775,998.90345,574View SEC Filing Icon  
7/15/2024Richard A HeymanDirectorSell1,270$24.80$31,496.00133,345View SEC Filing Icon  
7/12/2024Anish PatelCOOSell17,475$25.07$438,098.25376,552View SEC Filing Icon  
7/12/2024Benjamin HohlCFOSell3,000$25.07$75,210.00View SEC Filing Icon  
6/27/2024Benjamin HohlCFOSell4,250$22.57$95,922.50View SEC Filing Icon  
6/25/2024Samuel KintzCEOSell12,000$21.66$259,920.001,075,525View SEC Filing Icon  
6/6/2024Anish PatelCOOSell1,133$20.06$22,727.98View SEC Filing Icon  
5/28/2024Benjamin HohlCFOSell4,250$23.18$98,515.00View SEC Filing Icon  
5/28/2024Samuel KintzCEOSell12,000$23.18$278,160.00View SEC Filing Icon  
5/16/2024Rishi GuptaDirectorSell1,033,300$22.14$22,877,262.00254,814View SEC Filing Icon  
5/14/2024Anish PatelCOOSell1,107$25.00$27,675.00View SEC Filing Icon  
5/9/2024Anish PatelCOOSell260$25.06$6,515.60View SEC Filing Icon  
5/6/2024Anish PatelCOOSell4,875$22.72$110,760.00View SEC Filing Icon  
5/3/2024Benjamin HohlCFOSell1,000$22.50$22,500.00View SEC Filing Icon  
4/29/2024Benjamin HohlCFOSell3,250$16.97$55,152.50View SEC Filing Icon  
4/29/2024Joseph P. LyssikatosinsiderSell12,000$17.92$215,040.00View SEC Filing Icon  
4/25/2024Samuel KintzCEOSell12,000$16.89$202,680.00View SEC Filing Icon  
4/15/2024Richard A HeymanDirectorSell1,270$19.99$25,387.30137,155View SEC Filing Icon  
4/11/2024Anish PatelCOOSell17,500$25.03$438,025.00View SEC Filing Icon  
4/11/2024Benjamin HohlCFOSell14,000$24.72$346,080.00View SEC Filing Icon  
4/11/2024Joseph P. LyssikatosinsiderSell30,000$25.04$751,200.00View SEC Filing Icon  
4/11/2024Rahul D BallalDirectorSell53,400$23.95$1,278,930.0022,341View SEC Filing Icon  
4/11/2024Samuel KintzCEOSell47,709$25.04$1,194,633.36View SEC Filing Icon  
4/8/2024Anish PatelCOOSell4,875$18.60$90,675.002,597View SEC Filing Icon  
4/4/2024Rahul D BallalDirectorSell3,485$19.15$66,737.7522,341View SEC Filing Icon  
4/1/2024Joseph P. LyssikatosinsiderSell12,000$18.60$223,200.00View SEC Filing Icon  
4/1/2024Rahul D BallalDirectorSell3,237$19.08$61,761.9622,341View SEC Filing Icon  
3/27/2024Benjamin HohlCFOSell3,250$18.25$59,312.50View SEC Filing Icon  
3/25/2024Samuel KintzCEOSell12,000$17.56$210,720.00View SEC Filing Icon  
3/19/2024Richard A HeymanDirectorSell1,270$14.50$18,415.00143,470View SEC Filing Icon  
3/6/2024Anish PatelCOOSell4,875$15.64$76,245.007,472View SEC Filing Icon  
2/29/2024Joseph P. LyssikatosinsiderSell12,000$16.42$197,040.00View SEC Filing Icon  
2/27/2024Benjamin HohlCFOSell3,250$16.97$55,152.50View SEC Filing Icon  
2/15/2024Richard A HeymanDirectorSell1,270$17.42$22,123.40144,740View SEC Filing Icon  
2/6/2024Anish PatelCOOSell4,875$15.11$73,661.2512,347View SEC Filing Icon  
1/31/20245Am Partners Vi, LlcMajor ShareholderSell500,000$15.00$7,500,000.00771,983View SEC Filing Icon  
1/30/2024Richard A HeymanDirectorSell1,270$16.41$20,840.70146,010View SEC Filing Icon  
1/29/2024Benjamin HohlCFOSell3,250$15.81$51,382.50View SEC Filing Icon  
1/29/2024Joseph P. LyssikatosinsiderSell12,000$15.85$190,200.00View SEC Filing Icon  
1/25/2024Samuel KintzCEOSell12,000$15.69$188,280.00View SEC Filing Icon  
1/22/2024Anish PatelCOOSell4,875$15.13$73,758.7517,222View SEC Filing Icon  
1/2/2024Anish PatelCOOSell11,000$15.00$165,000.0022,097View SEC Filing Icon  
1/2/2024Benjamin HohlCFOSell9,383$15.01$140,838.83View SEC Filing Icon  
12/26/2023Anish PatelCOOSell102$15.01$1,531.0235,637View SEC Filing Icon  
12/26/2023Benjamin HohlCFOSell100$15.00$1,500.00View SEC Filing Icon  
12/26/2023Samuel KintzCEOSell12,000$14.64$175,680.00View SEC Filing Icon  
12/22/2023Anish PatelCOOSell983$15.03$14,774.4935,739View SEC Filing Icon  
12/22/2023Benjamin HohlCFOSell1,030$15.07$15,522.10View SEC Filing Icon  
12/22/2023Samuel KintzCEOSell8,175$13.05$106,683.75View SEC Filing Icon  
12/21/2023Joseph P. LyssikatosinsiderSell20$13.00$260.00View SEC Filing Icon  
12/21/2023Richard A HeymanDirectorSell7$13.00$91.00147,448View SEC Filing Icon  
12/20/2023Samuel KintzCEOSell7,779$13.01$101,204.79View SEC Filing Icon  
12/19/2023Joseph P. LyssikatosinsiderSell200$13.00$2,600.00View SEC Filing Icon  
12/19/2023Richard A HeymanDirectorSell255$13.00$3,315.00149,565View SEC Filing Icon  
11/3/2023Joseph P. LyssikatosinsiderSell8,546$13.08$111,781.68View SEC Filing Icon  
11/3/2023Samuel KintzCEOSell8,026$13.08$104,980.08View SEC Filing Icon  
9/29/2023Joseph P. LyssikatosinsiderSell12,000$13.62$163,440.00View SEC Filing Icon  
9/26/20235Am Partners Vi, LlcMajor ShareholderSell197,500$15.00$2,962,500.00854,796View SEC Filing Icon  
9/25/2023Samuel KintzCEOSell12,000$13.81$165,720.00View SEC Filing Icon  
8/24/20235Am Partners Vi, LlcMajor ShareholderSell440,000$16.00$7,040,000.00887,507View SEC Filing Icon  
See Full Table
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Enliven Therapeutics (NASDAQ:ELVN)

95.08% of Enliven Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Enliven Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2024Verition Fund Management LLC10,610$0.27M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC99,416$2.54M0.0%N/A0.210%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC26,168$0.67M0.0%+12.7%0.055%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC234,856$6M3.2%N/A0.497%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC296,368$7.57M6.1%-25.5%0.627%Search for SEC Filing on Google Icon
11/13/2024FMR LLC6,296,179$160.80M0.0%+10.6%13.328%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 17,282$0.44M0.0%+25.6%0.037%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.255,277$6.52M0.0%+10.4%0.540%Search for SEC Filing on Google Icon
11/7/2024First Turn Management LLC535,092$13.67M2.2%+29.5%1.133%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC21,117$0.54M0.0%+1,226.4%0.045%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.9,085$0.23M0.0%+64.4%0.019%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC7,483$0.19M0.0%-60.3%0.016%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC10,013$0.26M0.0%N/A0.021%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company13,764$0.32M0.0%N/A0.029%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP192,100$4.49M0.0%N/A0.408%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP595,000$13.91M1.1%-62.2%1.265%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC119,789$2.80M1.0%-5.6%0.255%Search for SEC Filing on Google Icon
8/8/2024First Turn Management LLC413,243$9.66M1.6%N/A0.879%Search for SEC Filing on Google Icon
8/8/2024Nicholas Investment Partners LP56,072$1.31M0.1%N/A0.119%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.27,651$0.65M0.0%+44.7%0.059%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC1,592$37K0.0%+87.3%0.003%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers49,627$1.16M0.0%+29.9%0.105%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp114,109$2.67M0.0%+49.2%0.243%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System19,141$0.34M0.0%-5.8%0.041%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC713,911$12.60M0.0%+74.8%1.519%Search for SEC Filing on Google Icon
5/16/2024Blackstone Inc.25,191$0.44M0.0%N/A0.054%Search for SEC Filing on Google Icon
5/15/2024Baker BROS. Advisors LP114,833$2.02M0.0%N/A0.244%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC9,510$0.17M0.1%N/A0.020%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,183,266$20.81M0.0%-3.9%2.517%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC9,430$0.17M0.0%-30.2%0.020%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.7,952$0.14M0.0%+67.0%0.017%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC5,485$76K0.0%-18.8%0.013%Search for SEC Filing on Google Icon
2/6/2024AJOVista LLC2,046$28K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank36,473$0.51M0.0%-10.3%0.089%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.12,305$0.17M0.0%+9.1%0.030%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.4,763$66K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC13,501$0.19M0.0%+17.8%0.033%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC8,708$0.12M0.0%+34.0%0.021%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.3,347$46K0.0%-69.1%0.008%Search for SEC Filing on Google Icon
11/13/2023FMR LLC3,676,213$50.22M0.0%-8.1%8.923%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank40,673$0.56M0.0%-17.3%0.099%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC13,629$0.19M0.0%-8.1%0.033%Search for SEC Filing on Google Icon
10/23/2023BML Capital Management LLC50,000$0.68M0.6%-32.6%0.121%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC11,460$0.16M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/15/2023HighVista Strategies LLC121,073$2.47M1.1%N/A0.294%Search for SEC Filing on Google Icon
8/15/2023Commodore Capital LP2,348,272$47.93M5.4%+35.6%5.707%Search for SEC Filing on Google Icon
8/11/2023VR Adviser LLC2,230,127$45.52M7.3%+0.7%5.423%Search for SEC Filing on Google Icon
8/10/2023Metropolitan Life Insurance Co NY1,279$26K0.0%N/A0.003%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.11,235$0.23M0.0%N/A0.027%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp80,924$1.65M0.0%+429.1%0.197%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can191,893$3.95M0.0%N/A0.467%Search for SEC Filing on Google Icon
7/24/2023BML Capital Management LLC74,232$1.52M1.4%-65.0%0.181%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC6,934$0.14M0.0%N/A0.017%Search for SEC Filing on Google Icon
7/18/2023Denali Advisors LLC9,900$0.20M0.1%N/A0.024%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC34,062$40K0.0%N/A0.519%Search for SEC Filing on Google Icon
5/16/2023Fairmount Funds Management LLC1,924,938$42.16M7.2%N/A29.353%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC710,644$15.56M0.8%N/A10.836%Search for SEC Filing on Google Icon
5/15/2023Commodore Capital LP1,731,365$37.92M5.8%N/A26.401%Search for SEC Filing on Google Icon
5/15/2023Logos Global Management LP401,229$8.79M1.3%N/A6.118%Search for SEC Filing on Google Icon
5/12/2023Mirabella Financial Services LLP11,670$0.26M0.0%N/A0.178%Search for SEC Filing on Google Icon
5/11/2023FMR LLC3,163,482$69.28M0.0%N/A48.239%Search for SEC Filing on Google Icon
4/20/2023Dorsey Wright & Associates1,237$27K0.0%N/A0.019%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Enliven Therapeutics logo
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.
Read More on Enliven Therapeutics

Today's Range

Now: $24.92
Low: $24.62
High: $27.20

50 Day Range

MA: $26.16
Low: $21.44
High: $29.55

52 Week Range

Now: $24.92
Low: $9.80
High: $30.03

Volume

198,582 shs

Average Volume

260,309 shs

Market Capitalization

$1.18 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Enliven Therapeutics?

Enliven Therapeutics' top insider investors include:
  1. Joseph P Lyssikatos (Insider)
  2. Samuel Kintz (CEO)
  3. 5Am Partners Vi, Llc (Major Shareholder)
  4. Anish Patel (COO)
  5. Rishi Gupta (Director)
  6. Richard A Heyman (Director)
  7. Rahul D Ballal (Director)
  8. Benjamin Hohl (CFO)
  9. Joseph P Lyssikatos (Insider)
Learn More about top insider investors at Enliven Therapeutics.

Who are the major institutional investors of Enliven Therapeutics?

Enliven Therapeutics' top institutional shareholders include:
  1. FMR LLC — 13.33%
  2. First Turn Management LLC — 1.13%
  3. Acuta Capital Partners LLC — 0.63%
  4. Charles Schwab Investment Management Inc. — 0.54%
  5. Ally Bridge Group NY LLC — 0.50%
  6. Walleye Capital LLC — 0.21%
Learn More about top institutional investors of Enliven Therapeutics stock.

Which institutional investors are selling Enliven Therapeutics stock?

Within the previous quarter, ELVN stock was sold by these institutional investors:
  1. Acuta Capital Partners LLC
  2. Exchange Traded Concepts LLC
In the previous year, company insiders that have sold Enliven Therapeutics company stock include:
  1. Joseph P Lyssikatos (Insider)
  2. Samuel Kintz (CEO)
  3. 5Am Partners Vi, Llc (Major Shareholder)
  4. Anish Patel (COO)
  5. Rishi Gupta (Director)
  6. Richard A Heyman (Director)
  7. Rahul D Ballal (Director)
  8. Benjamin Hohl (CFO)
  9. Joseph P Lyssikatos (Insider)
Learn More investors selling Enliven Therapeutics stock.

Which institutional investors are buying Enliven Therapeutics stock?

During the previous quarter, ELVN stock was acquired by institutional investors including:
  1. FMR LLC
  2. Ally Bridge Group NY LLC
  3. First Turn Management LLC
  4. Walleye Capital LLC
  5. Charles Schwab Investment Management Inc.
  6. Quest Partners LLC
  7. Verition Fund Management LLC
  8. SG Americas Securities LLC
Nvidia’s world of pain awaits
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Click play to stream The Final Frontier at no cost